Our Medical Device Development Difference
REDUCING R&D DEVELOPMENT FEES
We've been the inventor and we didn't like the development fees. We also didn't like all the outsourcing of specialties. We've built our business to reduce those pain points and to reward the inventor for their brilliant idea. Our inventors spend less, develop faster and commercialize easier than our competitors.
The average time to commercialize a medical device in the United States ranges from 3-7 years. Vita Group aims to commercialize as quickly as possible to provide the highest return on investment. Depending on project demands and class type, we aim to bring most projects to market in 2-3 years.
We've internally hired specialists to fulfill the roles of engineering, regulatory, manufacturing, warehousing, marketing, sales, and distribution. This means less outsourcing, less confusion, and a new streamlined approach to medical device development.
PARTNERSHIP BUSINESS MODEL
We believe in the projects we onboard and to reduce the out-of-pocket fees to our inventors, we offer a partnership model. Partnerships become available at the conclusion of Phase 1 and balance development fees with equity splits. This allows us to reposition front-end fees for back-end returns.
Our Phase Process & A La Carte Services
Featured Projects & Portfolio
The Brekka device is intended to facilitate the delivery of implants by providing a shell-tissue ...
StingRay™ is intended to facilitate the delivery of silicone gel implants by providing ...
ASK US ABOUT ... DEVICE & TISSUE-TO-SKIN ANIMATIONS.
“Innovating with Vita Group was the best decision I ever made. They let me continue to be a surgeon, operate and take care of patients while not giving up on my dream of device development. They do all the heavy lifting and keep me in the loop on all the details."
Karan Chopra, MD